CGP-7930

Chemical compound From Wikipedia, the free encyclopedia

CGP-7930 was the first positive allosteric modulator of GABAB receptors described in literature.[1][2][3][4] CGP7930 is also a GABAA receptor positive allosteric modulator and a blocker of Potassium channels.[5]

CAS Number
Quick facts Identifiers, CAS Number ...
CGP-7930
Identifiers
  • 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC19H32O2
Molar mass292.463 g·mol−1
3D model (JSmol)
  • CC(C)(C)c1cc(CC(C)(C)CO)cc(C(C)(C)C)c1O
  • InChI=1S/C19H32O2/c1-17(2,3)14-9-13(11-19(7,8)12-20)10-15(16(14)21)18(4,5)6/h9-10,20-21H,11-12H2,1-8H3 ☒N
  • Key:XLWJPQQFJNGUPA-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)
Close

CGP7930 was developed in Novartis and has been used extensively for scientific research. It has anxiolytic effects in animal studies,[6][7] and has a synergistic effect with GABAB agonists such as baclofen and GHB,[8][9] as well as reducing self-administration of alcoholic drinks and cocaine.[10][11]

CNS Review:[12]

Synthesis

The chemical synthesis has been described:[13] Starting material:[14] Product of first step:[15][16]

2,6-Di-tert-butylphenol is treated with formaldehyde, base and methanol to give [87-97-8] (2). Base catalyzed reaction with isobutaldehyde gives CGP-13501 (3). Hydride reduction of the aldehyde gives the primary alcohol.

According to Krysin (Russia), 2,6-Di-tert-butylphenol is reacted with Neopentyl glycol with lye in an autoclave. Although 1 step reaction, yield was quoted as merely 15%.[17]

See also

References

Related Articles

Wikiwand AI